Wüthrich B, Arrendal H, Lanner A
Schweiz Med Wochenschr. 1981 Nov 14;111(46):1756-65.
The concentrations of venom specific IgE (Phadebas-RAST) and IgG (Phadebas IgG-RAST) were monitored in sera of 22 patients with histories of systemic anaphylactic reactions following insect stings who underwent immunotherapy with venom extracts (bee venom and/or yellow jacket venom). Analysis of the immunological parameters during immunotherapy revealed great individual variation in the degree of response concerning both specific IgE and IgG antibodies. Nevertheless, four typical patterns of immune response could be found. The majority of the patients were able to produce high titers of IgG "blocking" antibodies without an IgE increase. Another group of patients had a marked rise in both specific IgG and IgE following the initial phase of hyposensitization. In contrast, one patient received venom injections without a significant IgG or IgE response. Finally, a small group of patients has a marked increase in specific IgE while synthesis of IgG was not observed. This IgE rise was the cause of systemic reactions in this group after the venom injections. Regular monitoring of venom specific IgE and IgG is useful in evaluating the degree of protection for the patient. Since an increasing IgG/IgE ratio must be obtained during immunotherapy, a knowledge of this relationship serves to adapt the individual treatment schedule.
对22例有昆虫叮咬后全身过敏反应病史且接受毒液提取物(蜂毒和/或黄胡蜂毒液)免疫治疗的患者血清中的毒液特异性IgE(Phadebas-RAST)和IgG(Phadebas IgG-RAST)浓度进行了监测。免疫治疗期间免疫参数分析显示,特异性IgE和IgG抗体的反应程度存在很大的个体差异。然而,可以发现四种典型的免疫反应模式。大多数患者能够产生高滴度的IgG“阻断”抗体而IgE不增加。另一组患者在脱敏初始阶段后特异性IgG和IgE均显著升高。相比之下,一名患者接受毒液注射后未出现明显的IgG或IgE反应。最后,一小部分患者特异性IgE显著增加,而未观察到IgG合成。这种IgE升高是该组患者注射毒液后发生全身反应的原因。定期监测毒液特异性IgE和IgG有助于评估患者的保护程度。由于在免疫治疗期间必须获得升高的IgG/IgE比值,了解这种关系有助于调整个体化治疗方案。